Merck & Co. and Schering-Plough Corp. will hold special meetings in August for their stockholders to approve their pending merger, which would make the combined company the world's second-largest prescription drugmaker.
Merck & Co. and Schering-Plough Corp. will hold special meetings in August for their stockholders to approve their pending merger, which would make the combined company the world's second-largest prescription drugmaker.